Expert of Market Insights

[expertofmarketinsights-blog]

Burn Care Market Necessity and Demand 2019 to 2026

Burn wounds are extremely painful, highly traumatic, and can lead to permanent scarring, disfigurement or even death. The management of these wounds is based on the injured area and severity and depth of burn. Burn care market has witnessed various technological advancements to treat all degrees of burns injuries. For instance, in July 2016, a combined team of researchers from the Boston University and Beth Israel Deaconess Medical Center developed new type of hydrogel bandage for burn patients. The hydrogel bandage seals the burn wounds to prevent entry of bacteria and proven to be easily removable.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1279

Market Dynamics

Increasing fire incidences are expected to lead to high demand for treatment of burn injuries, which is expected to drive growth of the burn care market. For instance, in January 2017 , according to the World Health Organization (WHO) data published in the African Journal of Emergency Medicines, burn injuries lead to around 18 million disability cases and over 2,50,000 deaths, annually, of over 90% deaths are registered from low-and middle-income countries. Moreover, the U.S. Fire Department responded to around 1.3 million fire incidences in 2016 and the National Fire Protection Association (NFPA) reported 3,280 civilian deaths and 15,700 civilian injuries in these incidences.

However, increasing number of product recalls due to product failure, component inconsistency, and packaging problems is expected to hamper growth of the burn care market. For instance, in March 2018, Integra LifeSciences Corp. recalled its Manuka Honey Wound Gel, which is used for wound healing of minor scalds and burns, minor cuts, lacerations, and minor abrasions. The reason for recall was incorrect gel part number listed in a master manufacturing record. The product was finally terminated in July 2018.

Global Burn Care Market- Drivers

The burn care market is expected to witness significant growth in the forecast period, owing to increasing incidence of burn injuries. For instance, according to the World Health Organization (WHO) data of March 2018, it is estimated that 180,000 deaths are caused by burns, annually, worldwide. Moreover, a vast majority of these deaths occur in low- and middle-income countries.

Increasing awareness regarding burn care is also expected to drive the burn care market growth over the forecast period. For instance, in February 2019, the American Burn Association organized National Burn Awareness Week in the first full week of the month, which served as an opportunity for burn care organizations, burn survivor support groups, public safety professionals, and injury prevention activists to increase awareness among the population about the frequency and causes of burn injuries in the U.S.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/1279

Global Burn Care Market- Competitive Landscape

Key players operating in the global burn care market include, Smith & Nephew Plc. Molnlycke, ConvaTec Inc., Integra LifeSciences Corporation, 3M, Coloplast A/S, Cardinal Health, Inc., DeRoyal Industries, Inc., Acelity LP, and Svenska Cellulosa Aktiebolaget (SCA).

 Detailed Segmentation:

Global Burn Care Market, By Product Type:

Advanced Burn Care

Biologics

Traditional Burn Care

Global Burn Care Market, By Burn Degree:

First-Degree

Second-Degree

Third-Degree

Other Degrees

Global Burn Care Market- Regional Insights

On the basis of region, the global burn care market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global burn care market during the forecast period, owing to presence of major market players in the U.S. such as Acelity LP, 3M, Coloplast A/S, and Integra LifeSciences Corporation.

Asia Pacific is expected to witness a rapid growth in the global burn care market, during the forecast period, owing to increasing government initiatives for burn treatment. For instance, in 2016, Government of India, introduced National Program for Prevention, Management, and Rehabilitation of Burn Injuries (NPPMRBI) in India. This program is implemented through state government medical colleges and district hospitals with the objective to reduce the incidence, morbidity, mortality, and disability due to burn injuries.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Burn Care Market Necessity and Demand 2019 to 2026

Burn Care Market Necessity and Demand 2019 to 2026

Burn wounds are extremely painful, highly traumatic, and can lead to permanent scarring, disfigurement or even death. The management of these wounds is based on the injured area and severity and depth of burn. Burn care market has witnessed various technological advancements to treat all degrees of burns injuries. For instance, in July 2016, a combined team of researchers from the Boston…

View On WordPress

[expertofmarketinsights-blog]

Veterinary Chemistry Analyzers Market: Future and Technological Advancement 2026

A veterinary chemistry analyzer (VCA) is used for in-house veterinary use. These analyzers are used to determine the concentration of certain metabolites, proteins, electrolytes or drugs in samples of urine, plasma, serum, cerebrospinal fluid and/or other body fluids of animals. In other words, VCA is a blood and urine testing instrument that analyzes around 12 biochemical tests simultaneously, by using the samples of either urine, serum or plasma in around 6 minutes. The types of analyzers include, urine analyzers, blood gas & electrolyte analyzers, glucometers, and others, which are used by hospitals, medical labs, and for home use. There are several types of tests such as hematology test that includes the cell counter for blood counts, immunoassays for detecting antibodies, and tests for ions that measure voltage differences and others.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2677

Veterinary Chemistry Analyzers Market - Drivers

Increasing animal population, growing pet adoption, increasing demand for pet insurance, along with high animal health expenditure and increase in number of veterinary practitioners are the factors driving growth of the veterinary chemistry analyzers market. According to the data published by American Pet Product Association (APPA) in 2018, total pet healthcare expenditure in America in 2017 was US$ 69.51 billion, which reached to US$ 72.13 billion in 2018.

Increasing prevalence of zoonotic diseases is further contributing towards growth of the veterinary chemistry analyzers market. According to the Centers for Disease Control and Prevention (CDC) in 2017, 3 out of 4 emerging infectious diseases in people are transmitted through animals. E.coli infection, chickungunya, dengue, and malaria are some mild to severe zoonotic diseases. According to the World Health Organization, in 2015, around 212 million cases of malaria were recorded worldwide with 429,000 deaths. Therefore, increasing need for control measures for zoonotic diseases is expected to boost the market growth. 

Key manufacturers in the market are focused on launching new veterinary chemistry analyzers, which is expected to boost the market growth. For instance, in November 2015, Diatron Group, global provider of hematology and clinical chemistry analyzers, launched a new 5-part differential veterinary hematology analyzer- the Abacus Vet5 in Dusseldorf at the Medica show.

Veterinary Chemistry Analyzers Market - Competitive Landscape

Some of the key players operating in the global veterinary chemistry analyzers market include, Abaxis Inc., IDEXX Laboratories Inc., Heska Corporation, DiaSys Diagnostics Systems, Derechos reservados Diconex, URIT Medical, Randox Laboratories Ltd., Eurolyser Diagnostica GmbH, ARKRAY Inc., and Alfa Wassermann Inc.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2677

Veterinary Chemistry Analyzers Market - Market Taxonomy

On the basis of modality, the global veterinary chemistry analyzers market is segmented into:

Benchtop

Portable

On the basis of product type, the global veterinary chemistry analyzers market is segmented into:

Instruments

Consumables

On the basis of animal type, the global veterinary chemistry analyzers market is segmented into:

Companion Animals

Livestock

On the basis of application, the global veterinary chemistry analyzers market is segmented into:

Blood Chemistry Analysis

Glucose Monitoring

Blood Gas & Electrolyte Analysis

Urinalysis

On the basis of end user, the global veterinary chemistry analyzers market is segmented into:

Hospitals

Clinical Laboratories

Veterinary Chemistry Analyzers Market - Regional Insights

On the basis of region, the global veterinary chemistry analyzers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds dominant position in the global veterinary chemistry analyzers market. This is owing to increasing animal health expenditure and high demand for animal-derived food in the region. According to American Pet Products Association, the total pet industry expenditure which includes the food, supplies and over the counter medicine, in 2017 was US$ 69.4 billion.

Key market players in the region are focused on adopting acquisition strategies to expand their geographical presence. For instance, in May 2018, Zoetis Inc. and Abaxis Inc. announced the definite merger agreement in which Zoetis Inc. will acquire Abaxis Inc. This acquisition is expected to improve Zoetis Inc.’s presence in the veterinary diagnostics sector.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Veterinary Chemistry Analyzers Market: Future and Technological Advancement 2026

Veterinary Chemistry Analyzers Market: Future and Technological Advancement 2026

A veterinary chemistry analyzer (VCA) is used for in-house veterinary use. These analyzers are used to determine the concentration of certain metabolites, proteins, electrolytes or drugs in samples of urine, plasma, serum, cerebrospinal fluid and/or other body fluids of animals. In other words, VCA is a blood and urine testing instrument that analyzes around 12 biochemical tests simultaneously,…

View On WordPress

[expertofmarketinsights-blog]

Outsourced Drug Discovery Market Set for Rapid Growth and Trend, by 2026

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organizations (CMO). Contract research organization provides support to the pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2847

Market Dynamics

New strategies adopted by key players related to outsourcing drug discovery is expected to drive the growth of the global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, the extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to preclinical drug development for the treatment of respiratory diseases and rare diseases.

The increasing number of drug discovery companies is expected to drive the growth of the global outsourced drug discovery market

The increasing number of new drug discovery companies is expected to drive the global outsourced drug discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi AppTec and launched a new drug discovery company, Faxian Therapeutics (Headquarter– New York, U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s drug design and synthesis services to improve health care needs.

Moreover, rising drug discovery services are expected to propel the growth of the global outsourced drug discovery market. For instance, in April 2019, Eurofins Discovery Services, a contract research organization, launched a new drug discovery service DiscoveryOne. The new approach is helpful for drug discovery research activities and preclinical developments. Hence, the launching of services related to drug discovery is expected to support the global outsourced drug discovery market growth.

Global Outsourced Drug Discovery Market - Competitive Landscape

Key players operating in the global outsourced drug discovery market are Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.

Detailed Segmentation:

Global Outsourced Drug Discovery  Market, By Drug Type:

Small Molecule Drugs

Large Molecule Drugs

Global Outsourced Drug Discovery Market, By Services:

Preclinical Development

Target Validation and Functional Informatics

Target Identification and Screening

Lead Identification and Candidate Optimization

Others

Global Outsourced Drug Discovery Market, By Application

Oncology

Ophthalmology

Hematology

Immunomodulation

Anti-Infective Drugs

Dermatology

Pulmonology

Cardiology

Others

Global Outsourced Drug Discovery Market, By End User

Pharmaceutical and Biotechnological Companies

Contract Research Organization

Contract Manufacturing Organization

Global Outsourced Drug Discovery Market- Regional Analysis

North America outsourced drug discovery market is expected to account for the largest market share, owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With this acquisition, Lambda Therapeutic Research entered into the U.S. market.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2847

Moreover, Europe is also projected to witness significant growth in the global outsourced drug discovery market, owing to increased merger and acquisition activities by key players in the region. For instance, in February 2019, Optimapharm, a clinical research organization (CRO) in Europe acquired Denothex, a CRO, for strengthening its presence in the European market particularly in France, Spain, Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe and Israel.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Outsourced Drug Discovery Market Set for Rapid Growth and Trend, by 2026

Outsourced Drug Discovery Market Set for Rapid Growth and Trend, by 2026

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organizations (CMO). Contract research organization provides support to the pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates various services such as biopharmaceutical development, biologic…

View On WordPress

[expertofmarketinsights-blog]

Cannabis Testing Services Market: Effect and Growth Factors Research and Projection 2018-2026

Cannabis Testing Services Market: Effect and Growth Factors Research and Projection 2018-2026

Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing,…

View On WordPress

[expertofmarketinsights-blog]

Cannabis Testing Services Market: Effect and Growth Factors Research and Projection 2018-2026

Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976

Market Dynamics

Cannabis testing service market is expected to witness significant growth over the forecast period, owing to legalization of cannabis for medicinal and recreational activities in key regions. For instance, in 2018, the parliament of Canada passed a law legalizing nationwide use of marijuana for recreational purposes. Furthermore, in February 2016, the Australia government amended the Narcotics Drugs Act 1967 to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favour growth of the commercial manufacturing of cannabis in different regions of Australia.

Increasing Research & Development Activities in Cannabis and Establishment of New Cannabis Testing Labs is expected to Drive Growth of the Cannabis Testing Service Market

Increasing research and development activities in cannabis to improve the productivity and quality of cannabis product is major driving force for the global cannabis testing service market growth. For instance, in November 2018, a team of researchers at the University of Guelph investigated technologies that can help in growing better quality marijuana. The team focused on controlled environment production of medical marijuana, with proprietary plant-growing technology, using chambers to monitor and regulate all variables throughout the growth.

Moreover, the research also involved sensors attached to the plants to analyze the plants’ response to different types of management strategies. This approach allowed the team to produce organically grown, pesticide-free, high-yielding strains of cannabis, in addition to consistent generation of high-quality products in every batch.

Global Cannabis Testing Service Market - Competitive Landscape

Key players operating in the global cannabis testing service market include, SC Laboratory, Eurofins Scientific, EVIO Labs, ProVerde Laboratories, Inc., Praxis laboratory Cascadia Labs, Encore labs, SGS Canada Inc., Pharm Labs LLC, and Agricore Laboratories.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2976

Detailed Segmentation:

Global Cannabis Testing Services Market, By Test Type:

Potency Testing

Terpene Profiling

Cannabinoid Profiling

Pesticide Screening

Residual Solvent Testing

Microbiological Screening

Other Tests

Global Cannabis Testing Services Market, By End User:

Cannabis Firms

Homecare Settings

Research Institutes

Global Cannabis Testing Service Market - Regional Insights

On the basis of region, the global cannabis testing service market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global cannabis testing service market during the forecast period, owing to increasing legalization of marijuana use in the U.S. by Federal Law. For instance, according to the Drug Policy 2018 report, on November 6, 2012, Colorado and Washington become the first two jurisdictions in the world to legalize marijuana for adult use. Moreover, in January 2018, Vermont became the first state to legalize marijuana through a state legislature. According to Governing 2019 report, 11 states have legalized marijuana for recreational use and 22 states have legalized for medical use in the U.S.

Europe is expected to foresee a rapid growth in the cannabis testing service market. The market in Europe is expected to gain momentum during the forecast period, owing to increasing number of players entering the U.K. cannabis testing service market by acquiring U.K-based cannabis testing laboratories. For instance, in July 2018, Sativa Investments PLC acquired PhytoVista Laboratories Ltd., a U.K-based lab that tests cannabis oils and hemp products.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Bioactive Peptide Market to Grow at a High CAGR of by 2026

Bioactive Peptide Market to Grow at a High CAGR of by 2026

The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides used as treatment therapy for most of…

View On WordPress

[expertofmarketinsights-blog]

Bioactive Peptide Market to Grow at a High CAGR of by 2026

The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides used as treatment therapy for most of the functional disorders such as irritable bowel disease is expected to enhance the market growth.

Market Dynamics

Technological innovations and developments in extraction techniques of bioactive peptide from natural sources is contributing to the market growth. For instance, an article was published in the journal of 'Critical reviews in environmental science and technology' in June 2019, regarding recent developments in native bioactive peptides targeting informatics, novel microbial protease mining, and screening methods, which are expected to accelerate development of genome-based microbial routes to therapeutic bioactive peptides, that promote human health and nutrition. As a result, technological advancements and genetically modified products is expected to propel the growth of the bioactive peptide market.

Increasing incidence of chronic diseases such as diabetes, cancer, cardiovascular disease, chronic obstructive pulmonary disease (COPD), and others is propelling the global bioactive peptide market growth.

Increasing incidence of diseases like diabetes, cancer, and respiratory disorders is expected to drive growth of the global bioactive peptide market. According to the International Federation of Diabetes, 2017 report, around 425 million adults were suffering from diabetes globally, and the number is expected to reach 629 million by 2045.

According to a press release on September 2018 by the International Agency for Research on Cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, 1 in 5 men, and 1 in 6 women worldwide develop cancer during their lifetime, and 1 in 8 men, and 1 in 11 women die from the disease.

Growing Demand for nutritional supplements

There has been increasing awareness among the populace regarding disease conditions, owing to initiatives and campaigns by government organizations, and increasing healthcare spending by government organizations are projected to drive growth of the global bioactive peptide market. According to Council for Responsible Nutrition (CRN) Washington, October 2018, Consumer Survey on Dietary Supplements, conducted by Ipsos Public Affairs found that 75% of U.S. adults take dietary supplements in 2018, compared to 65% in 2009.

Key Players

Major players operating in the global bioactive peptides market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy among others.

Global Bioactive Peptide Market, By Source:

Plant

Milk

Eggs

Meat

Fish

Global Bioactive Peptide Market, By Therapeutic Area:

Global Bioactive Peptide Market, By Distribution Channel:

Antihypertensive

Antioxidant

Immunostimulatory

Antimicrobial

Diabetes

Others

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Bioactive peptides are amino acids combined together through a covalent bond. Bioactive peptides are extracted from various natural sources, thereby providing a variety of health benefits such as better cardiovascular, digestive, endocrine functioning, as well as the immune and nervous system. They are also used in protecting important contents of food and beverages, resulting in decreased oxidation and degradation of the products. Although these peptides are extracted from natural sources, some of them have been designed with the help of chemical synthesis.

Furthermore, bioactive peptides, as well as bioactive proteins are part of a balanced diet. The prominent factor driving the market demand is increasing incidence of chronic diseases, and growing geriatric population. Moreover, growing interest in bioactive peptides is driving the scientific community and the food industry to develop new food additives and functional products based on bioactive peptides.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Gel Permeation Chromatography (GPC) Market To Be At Forefront By 2025

Gel permeation chromatography is a size exclusion based chromatography technique. It is most commonly used to determine the molecular weight distribution of the polymer which confirms its purity. It is also used to separate various component of the analyte, based on their retention with stationary phase. Both aqueous and non-aqueous mobile phases are used in gel permeation chromatography based on analyte and column’s packing material. Variety of detectors can be used such as refractive index detectors, light scattering detectors, viscometer, and diode array/UV detectors, which measures concentration, informs about size, and structure of analyte.

Request For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/28

Market Dynamics

Major factor driving growth of the gel permeation chromatography market is increasing research for chronic disease such as cancer. According to report by International Agency for Research on Cancer (IARC) in 2012, around 14.1 million new cases, 8.8 million deaths, and 32.6 million people were suffering from cancer worldwide. North America has high incidence of cancer with an estimated 1,735,350 new cancer cases to be diagnosed in the U.S. in 2018, as reported by American Cancer Society’s Cancer Journal for Clinicians. Companies are focusing on protein-based gene therapy also termed as personalized medicine that studies various body proteins such as monoclonal antibodies for developing novel therapies. GPC system is used in this process to know molecular weight, separation as it would decide final physical attribute of the analyte. Expiration of patent of blockbuster drugs such as Rituximab is leading to development of biosimilar versions of the same drugs, where GPC system is important to compare and profile biosimilar and innovator molecule. Major players are also bringing products with new technologies and multiple detectors to precisely analyze the polymers.

Increasing research and development by pharmaceutical and biotech companies in chronic disease is expected to propel growth of the gel permeation chromatography market

Increasing focus on research and development activities by pharmaceutical and biotech companies across the globe, targeting chronic diseases such as cancer to bring novel therapies, is expected to aid in growth of the market. These are protein (Natural Polymer) based therapies such as CAR-T cell therapy, antibody-drug conjugates, and immune check point inhibitors. According to report in 2017 by International Federation of Pharmaceutical Manufacturers and Associations, research based pharmaceutical and biotech companies annually invest around US$ 149 billion on research and development. Over 7,000 molecule are under investigation, out of which around 2,000 candidate are for cancer. Therefore, separation and characterization of new chemical entity, which are polymer-based is possible efficiently with gel permeation chromatography and this is expected to aid in growth of the market in the near future.

Key players operating in gel permeation chromatography market are Agilent Technologies, Waters Corporation, Malvern Panalytical, Shimadzu Corporation, and Polymer Char.

Detailed Segmentation:

Global Gel Permeation Chromatography Market, By Product Type:

Gel Permeation Chromatography System

Detectors

Columns

Pumps

Global Gel Permeation Chromatography Market, By End User:

Pharmaceutical and Biotech Companies

Research Institutes

Regulatory approvals for use of novel excipients (Polymers) is expected to drive growth of the gel permeation chromatography market

Pharmaceutical and biotech companies widely use polymers as excipient (Binder, Diluent, coating agents, suspending agent, viscosity agent, and Disintegrant) to produce variety of dosage form. There is increasing use of natural polymers instead of synthetic one due to inertness, low cost, and higher acceptability of consumers towards natural polymers. Various recently launched natural polymers from different manufacturers are Solutol HS 15, Soluplus, Kollicoat Smartseal 30 D, Polyplasdone Ultra, and Prosolv ODT. However, before using polymers in formulation, end user (pharmaceutical and biotech companies) has to be confident about quality of polymers used as excipients. Click to Read More On Gel Permeation Chromatography (GPC) Market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Gel Permeation Chromatography (GPC) Market To Be At Forefront By 2025

Gel Permeation Chromatography (GPC) Market To Be At Forefront By 2025

Gel permeation chromatography is a size exclusion based chromatography technique. It is most commonly used to determine the molecular weight distribution of the polymer which confirms its purity. It is also used to separate various component of the analyte, based on their retention with stationary phase. Both aqueous and non-aqueous mobile phases are used in gel permeation chromatography based on…

View On WordPress

[expertofmarketinsights-blog]

Hutchinson-Gilford Progeria Treatment Market Industrial Progress 2018 to 2026

Hutchinson-Gilford progeria syndrome is a genetic condition characterized by the dramatic, rapid, appearance of aging from the childhood. Hutchinson-Gilford progeria syndrome is caused by a mutation in the lamin A (LMNA) gene. The affected children develop a characteristic facial experience including prominent eyes, small chin, protruding ears, thin lips and a thin nose with a beaked tip. This syndrome also causes hair loss (alopecia), joint abnormalities, aged-looking skin, and a loss of fat under the skin (subcutaneous fat). Moreover, patients of Hutchinson-Gilford progeria syndrome experiences severe hardening of the arteries (arteriosclerosis) from the childhood. The condition worsens with age and increases the risk of heart attack or stroke even at a young age.

Request For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/35

Hutchinson-Gilford progeria is a rare condition that affects about one in four million newborns worldwide according to the National Institutes of Health (NIH). Until now more than 130 cases have been reported as per the NIH statistics. The affected patients live up to 30 years maximum, with an average life span of 13 years. Nearly 90% of the patients die from complications related to atherosclerosis. Till 2012 there wasn’t any effective treatment therapy discovered for Hutchinson-Gilford progeria syndrome. The treatments available focused mostly on reducing cardiovascular symptoms and growth abnormalities.

Farnesyltransferase Inhibitor (FTI)

In 2012, findings of the first clinical trial of the drug Lonafarnib, a farnesyltransferase inhibitor (FTI), gave a new hope for the treatment of children with Hutchinson-Gilford progeria syndrome. Clinical trial results demonstrated improvement in weight gain, increase in bone mineral density, reduced vascular stiffness, and improved sensorineural hearing in patients with progeria. Previous treatments with growth hormone, and Sulforaphane helped in reducing the symptoms, and prolong a child’s life. However, it is essential that the patient regularly visits the cardiologist. Rapamycin is one other drug used before, that demonstrated to reverse nuclear blebbing, retard cellular senescence, and facilitate degradation of progerin.

Recently in 2015, the scientists at the Agency for Science, Technology & Research (A*STAR) successfully established a model of Hutchinson-Gilford progeria syndrome. The study conducted by this organization proposed a model which implies that progerin is linked to telomeres. Progerin induces a reduction in heterochromatin, a tightly packed form of DNA, making telomeres in the cell more fragile and susceptible to damage. The damaged telomeres in turn trigger premature cellular aging. This model is radically different from the one believed earlier – the gene progerin caused the nucleus to be deformed, thereby weakening the ability of cells to divide and proliferate. The altered progerin protein makes the nuclear envelope unstable and progressively damages the nucleus, making cells more likely to die prematurely.

Researchers are working to determine how genetic changes further leading to the characteristic features of Hutchinson-Gilford progeria syndrome. Continuous advancement in research with increased understanding of the human aging will provide valuable insights and aid in the treatment of this disease. Click To Read More On Hutchinson-Gilford Progeria Treatment Market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Hutchinson-Gilford Progeria Treatment Market Industrial Progress 2018 to 2026

Hutchinson-Gilford Progeria Treatment Market Industrial Progress 2018 to 2026

Hutchinson-Gilford progeria syndrome is a genetic condition characterized by the dramatic, rapid, appearance of aging from the childhood. Hutchinson-Gilford progeria syndrome is caused by a mutation in the lamin A (LMNA) gene. The affected children develop a characteristic facial experience including prominent eyes, small chin, protruding ears, thin lips and a thin nose with a beaked tip. This…

View On WordPress

[expertofmarketinsights-blog]

Medical Claims Processing Services Market Widespread Research and Fundamental study to 2026

Medical Claims Processing Services

As the global healthcare industry continues to expand, healthcare providers are facing challenges in maintaining optimal quality of services. Number of claims are increasing with increasing coverage of medical insurance. Processing such claims along with the administrative tasks, patient care, and other daily operations is cumbersome and involves high cost and trained personnel. Processing of claims in-house by the healthcare provider has the risk of delayed payment, error in amounting, and customer dissatisfaction. Moreover, healthcare providers need to be updated with changes in regulations and new services and products being launched in the market for in-house processing of claims.

Request For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/41

Outsourcing of medical claims ensures minimal error and faster turnover, thereby reducing risk of delayed payment. According to the American Medical Association (AMA), 20% error rate among health insurers represents an intolerable level of inefficiency that causes a loss of around US$ 17 billion each year. This depicts a strong need for adequate and technically advanced claim processing services and software to reduce the economic burden.

Earlier, claims were submitted using a paper form. However, with the advent of healthcare IT, most claims are now electronically made i.e. electronic data interchange. The onset of online medical claim process reduces paperwork of healthcare providers and also assists in rendering adequate fees for the services. Usually the medical claims are processed by medical claims examiners or medical claims adjusters. In case of large number of claims though, medical directors review the claim and validate its authenticity.

The medical claims processing services market can be analyzed for:

Claim indexing

Claim investigation

Claim adjudication

Claim repricing

Claim settlement

Litigation management and

Information management services

Most of these services are either directly rendered by the service provider or can be outsourced to third-party organizations for code assignment and claim processing. Outsourcing concept reduces the burden as well as cost for insurance companies. Most billing services charge a percentage of the collected claim amount. The concept of EMR/EHR has also streamlined claim processing, as patient records are electronically transmitted to the billing service providers, which eliminates the process of recording and sending paper-based records.

Medical Claims Processing Services Industry Outlook is Positive in Developed Economies

According to Swiss Re, the global insurance penetration rate was a mere 6.2% in 2014, with India having insurance penetration rate on the lower side, at just 3.9% in the same year. Moreover, the study found that the insurance penetration rate fell to 3.2% in 2015 in India. The U.S., Japan, U.K., Australia, Italy, and France are some of the leading countries in the global medical claims processing services market, owing to higher insurance penetration rate, increasing number of claims, and growing demand from healthcare providers. Furthermore, favorable healthcare policy and government initiatives such as Affordable Care Act have also boosted demand for medical claim processing services in the U.S. Europe is quickly emerging as another important Medical Claims Processing Services Market.

Although the medical claims processing services market in Asia Pacific and Rest of the World are still at a very nascent stage, high population base and increasing awareness for insurance in the middle income group is expected to boost demand for medical claim processing services in the near future.

Medical Claims Processing Services Market Competitive Landscape

Some of the prominent players in the global medical claims processing services market include Aetna Inc., Infinit Healthcare, Invensis Technologies Pvt. Ltd, Humana Inc., UnitedHealth Group, Telegenisys Inc., and Health Care Service Corp.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[expertofmarketinsights-blog]

Medical Claims Processing Services Market Widespread Research and Fundamental study to 2026

Medical Claims Processing Services Market Widespread Research and Fundamental study to 2026

Medical Claims Processing Services

As the global healthcare industry continues to expand, healthcare providers are facing challenges in maintaining optimal quality of services. Number of claims are increasing with increasing coverage of medical insurance. Processing such claims along with the administrative tasks, patient care, and other daily operations is cumbersome and involves high cost and…

View On WordPress

[expertofmarketinsights-blog]

Mobile Health Apps and Solutions Market: Future and Technological Advancement 2026

Mobile Health Apps and Solutions Market Overview

Proliferation of mobile devices provides an entirely new and effective dimension to the healthcare industry, wherein solutions can be provided to end users in an extremely easy-to-use manner that can be accessed irrespective of the use location. Advent of mHealth apps and solutions have led the healthcare solutions market to expand its reach from hospitals to primary care and office space. The industry is witnessing influx of various start-ups venturing into the market, leading to high competition.

Request For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/42

Mobile health apps segment is expected to grow at impressive double digit CAGR over the forecast period (2016–2024), creating new market opportunities for the players worldwide.

Proliferation of smartphones fueling mobile health apps and solutions market growth

Over 600 million people are expected to use mobile healthcare apps by 2017, creating a highly lucrative market opportunity for healthcare players. The industry is projected to be mainly driven by growing healthcare expenditure and consumer changing lifestyle. Advancements in computing ability of mobile devices would bridge the gap between patient’s expectation and treatment delivered. The technology is perceived to be an enabler of quality healthcare.

Though the industry is set to grow at a robust rate, lack of collaborations among healthcare service providers and low healthcare apps utilities awareness among the masses are major industry pitfalls.

Mobile Health Apps and Solutions Market Taxonomy:

Coherent Market Insights has segmented the mobile health apps and solutions market on the basis of following:

Operating System

Product Type

Therapeutic Application

Devices

On the basis of operating system, iOS mHealth app is expected dominated the market in 2015. However, the segment is expected to lose major market share to android app segment by 2024.

Among device segments, smartphones are expected to dominate the market, followed closely by tablets through 2024. Tablets are expected to be most prominent in developed regions.

Mobile Health Apps and Solutions Market – Competitive Landscape

Major players in the mobile health apps and solutions market include Runtastic, Nike, MyFitnessPal, Azumio, GP Apps, Pacer Health, Kinosis, GoodRX, Leafly, and Epocrates.

Emergence of connected and integrated healthcare solutions driving growth of North America and Europe markets

The mobile health apps and solutions market report covers market analysis across regions namely North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Geographically, Europe, followed closely by North America is expected to dominate the market throughout the forecast period. Presence of leading mHealth service providers, along with wide availability of high-quality healthcare amenities, and increased healthcare awareness is expected to bolster market growth.

The market in Asia Pacific is growing at the fastest rate, driven primarily by rising demand in China and India. China and India account for over 36% of global population, creating lucrative market opportunity for players in the long run. Markets in Latin America, Middle East, and Africa are expected to grow at a relatively sluggish rate, with upward growth traction expected in the mid of the forecast period.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]